Celyad Oncology SA

Quick facts

Marketed products

• Fludara · Oncology

Phase 3 pipeline

• ENDOXAN · Oncology
  ENDOXAN (cyclophosphamide) is an alkylating agent that cross-links DNA to inhibit cell division and induce apoptosis in rapidly dividing cells.
• Injection of C3BS-CQR-1 · Oncology
  C3BS-CQR-1 is an allogeneic CAR-T cell therapy engineered to target and kill cancer cells expressing specific tumor antigens.
• Sham, no injection
  This is a sham treatment with no active pharmaceutical ingredient, designed as a control in clinical trials.

Phase 2 pipeline

• C-Cure

Phase 1 pipeline

• CM-CS1 T-cell infusion
• CYAD-02
• CYAD-101
• CYAD-211
• NKR-2

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Celyad Oncology SA portfolio CI brief
• Celyad Oncology SA pipeline updates RSS